The first week of healing, she thought the worst part was the pain.

Her tongue swelled until she couldn’t close her mouth properly, and then, slowly, went down. Her nipples throbbed day and night under silk, crusted, wept, were rinsed with Halo’s pale blue compound morning and evening from a little steel spray bottle that stung like a slap and then went cool. Her labia ached around the rings. And the triangle — the triangle was a constant, deep, hot pulse at the base of her clit, worse when she walked, worse when she sat, worse when she thought about it, and she thought about it all the time.

By the second week the pain had faded to soreness, and she understood that the pain had been a mercy.

Because the pain had been something. It had been sensation. It had been a thing happening to her clit, even if the thing was hurt. And as it faded it left behind exactly what Abby had promised on the table: nothing. A swollen, lifted, newly pierced clit hanging in the open air inside a steel lattice, held out from her body by the bar beneath it as if presented on a tray, with nothing on it. Nothing against it. Nothing touching it anywhere, at any time, for any reason, and her thighs held apart by steel so that she couldn’t even press them together and imagine.

The bar came off on day fifty. Abby unlocked it from the bands in the back room on a Sunday — the bands themselves stayed, as they always stayed now — and Lea stood up from the table and pressed her thighs together for the first time in two weeks, steel band against steel band, and felt — the cage. Steel bars, a centimetre clear of her skin. Her thighs squeezed the cage and the cage didn’t move and her clit hung inside it, untouched, exactly as before. The bar had been a lesson, she understood, and the lesson was over, and the cage had learned it for them.

She stopped being able to work properly in the third week.

Not badly. She was too good at it to work badly. But she would sit at her corner desk with a draft of something open and find, twenty minutes later, that she had read the same paragraph nine times and that her hips were moving. Small circles. Forward and back. As if she were trying to press herself against the chair, the cage, the air — anything. She’d stop. Ten minutes later she’d be doing it again.

The plug was worse, now. The app still ordered it some mornings, and she still docked it, and it still sat there, and before the fitting it had been a torment of fullness, of being made to carry something. Now it was the only thing inside her except the ring at the top of her, and she found herself clenching around it — deliberately, rhythmically — for the pressure it gave, the faint secondhand pressure it sent forward through her toward the clit that nothing touched. Clenching and clenching. In meetings. On calls.

And every time she clenched, she felt the ring. Deep in her. Wedged against the end of her. Not moving. Listening.

It doesn’t do anything yet. It just sits there and listens.

She’d tell herself it was nothing. A pessary. Women wore pessaries — she’d looked it up — for prolapse, for continence; it was a medical device, a ring, it sat there. She’d tell herself that and then she’d clench around the plug and feel the ring receive it, deep, and think: Listens to what?

You. It’s already started.

She put that in a report. I clench to feel the ring. I think I’m trying to make it do something. I don’t know what I want it to do.

Abby’s reply: Yes, you do.

On a Thursday night in the fourth week, Abby didn’t send her to bed.

She sent her to the back room, and told her to kneel on the rug, and cuffed her wrists behind her with the heavy leather cuffs and padlocks, and clipped a short chain from them to the D-ring of the collar, so that her hands were held high between her shoulder blades and she had to kneel very upright. Lea knelt, caged, naked, upright, facing the table. The hard light was off. Only the amber lamp.

Abby took off her robe.

Lea had never seen her naked. Not once in six years of friendship, and not once since September. She had been naked for Abby a hundred times — strapped, spread, hooded, examined, pierced — and Abby had stayed in her trousers and her cashmere, or her sweatpants, or her robe, and had never so much as pushed up her sleeves. Lea had stopped expecting it. She had stopped, she realized now, even imagining it. Some part of her had decided that Abby didn’t have a body, the way a doctor doesn’t, or a judge.

Abby had a body. Forty-two years old and strong and unhurried and pale in the lamplight, with small high breasts and a soft belly and a long scar on one hip that Lea had never known about. She climbed up onto the table — the table, the leather still faintly warm from the lamp — and lay back on it, where Lea had lain, and let her knees fall open toward Lea, and looked at her down the length of her own body.

“You’ve been wanting this,” she said. “Not me. This.” She ran her own hand down over her belly, slowly, between her legs. “Someone being allowed.”

And she touched herself.

Lea knelt on the rug and watched. She had no choice. Her hands were chained high behind her; she could not cover her eyes; and Abby had said, before she began, if you look away, I’ll stop and we’ll start again from the beginning, and Lea did not doubt it. So she watched. She watched Abby’s fingers part herself, wet, already, and circle, slowly. She watched Abby’s hips lift into her own hand. She heard the small slick sounds — the same sounds Lea had made on the phone in September, on her back, two fingers, efficient circles, before any of this, before the lock — and she heard Abby’s breathing change.

It was the most unbearable thing that had ever been done to her. More than the needle. More than the hood. Because it wasn’t being done to her at all. She was on the floor, with her clit lifted and swollen and screaming in its cage, untouched for five weeks — and four feet away, on the table that had been built for her, someone was simply doing it. Just reaching down and doing it. As if it were nothing. As if it were allowed.

Her hips were moving. She couldn’t stop them. Little desperate jerks forward, toward nothing, the cage swinging in the air, the rings swaying inside it, her body fucking the empty space in front of it in short shameful thrusts — and she could see herself doing it, in the long mirror over the sink, beside the image of Abby on the table, and she couldn’t stop.

“Look at you,” Abby said, breathless. Her fingers hadn’t slowed. “Look what you’re doing.”

“Please—”

“No.” Abby’s back arched. “No one’s touching you. No one’s going to.” Her voice was going. “I want you — to see — what it looks like —”

She came. Lea watched her come. Her whole body went taut on the table and her heels pressed into the leather and she made a sound — low, long, completely unguarded, a sound Lea would hear in her sleep for weeks — and her hand kept moving through it, and then slowed, and stopped, and she lay there breathing with her eyes closed and her knees fallen open and her fingers still resting on herself, wet, in the lamplight.

Lea was crying. She hadn’t noticed when she’d started. She knelt there with her hands chained up behind her and her hips still jerking at nothing and tears running off her chin onto her bare breasts, onto the little tourmaline stones, and she couldn’t stop either.

After a while Abby sat up. She climbed down off the table and crossed the rug and stood in front of Lea, naked, flushed, smelling of herself, and crouched, and held her wet fingers an inch from Lea’s face.

Lea’s mouth opened. She didn’t decide to. It just opened.

“No,” said Abby gently. “Tongue’s still healing. Anand said nothing in the mouth for four weeks.” She looked at her fingers, and then at Lea’s open, wet, desperate mouth. “That was four weeks ago yesterday. But I think we’ll give it another week, to be safe.”

She stood up, and put her robe back on, and went to wash her hands at the steel sink.

She started sleeping in a hood in the fifth week.

It wasn’t the dinner hood, or anything like it. It was soft — a thin, stretchy, black fabric, almost silk, that went over her head like a stocking and laced lightly at the back, with wide open nose ports and a padded panel over each ear. “For sleep,” Abby said, lacing it, the first night. “You haven’t slept properly since the fitting. Your trace is a mess. This’ll help.”

Inside, behind each ear panel, there was a faint hiss. White noise. Soft, steady, even — like rain on a roof very far away, or the sea in a shell. Lea knew it the instant it came on. The headphones in the back room, the night of the ultrasound. The same rain. She went rigid, and Abby’s hand settled on her tethered wrists, and the hiss went on, and nothing else happened, and slowly, slowly, she let it fill the dark of the hood and push everything else out. The house. Abby’s breathing. Her own pulse. Lea lay with her wrists tethered and the static in her ears and, for the first time in weeks, slept through until morning.

She slept in it most nights after that. She came to want it. By the third week she’d find herself lying in the dark at eleven, waiting for Abby to come to bed with it in her hands, and when Abby did, Lea would lift her head off the pillow without being asked.

Sometimes, in the static, she thought she heard something.

Not words. Not at first. A texture under the hiss, a shape. Like a radio in another room. She’d lie there half asleep and strain toward it, and it would slip away, and she’d decide she’d imagined it, and sleep.

Then one night, near the edge of sleep, she heard it clearly. Abby’s voice. Very low. Very far under the static, like something at the bottom of a pool.

— close is where you live —

She came awake all at once, rigid. Listened. Nothing. Rain on a roof. The sea in a shell.

“Abby?” Her voice was muffled in the fabric.

Beside her, Abby stirred. “Mm.”

“Is there — is something playing? In the hood?”

A pause. “White noise.”

“I heard you. Your voice. I heard you say—”

“You were dreaming.” Abby rolled over. Her hand found Lea’s tethered wrists in the dark and rested on them, warm and heavy. “Your trace says you were in stage two. People hear voices in stage two. It’s called a hypnagogic — you know what it’s called. Go back to sleep.”

Lea lay in the static. She did know what it was called. She’d read about it, once. It was common. Everyone heard things on the edge of sleep. She’d been dreaming. She must have been.

She listened for a long time and heard nothing but the hiss, and Abby’s hand on her wrists, and eventually she slept.

She didn’t hear it again. Not clearly. But some mornings, at her desk, in the north light, a sentence would surface in her head, whole, in no voice she recognized — the exit is the instrument, or she’s started to protect the surprise, or every edge is mapped — and she’d stop, with her pen in the air, and not know where it had come from, and decide it was her own.

The FDA brief came on a Monday in the fifth week. It arrived the way all of Lea’s work arrived — as an email from Abby, subject line For your action, with a one-page memo attached and a deadline.

For your action

Prepare and file De Novo classification request, Halo Continuous Platform (HCP-2). Target filing: Feb 19. Technical annex from Priya to follow.

Lea opened the memo. It was half a page.

Device description: an implantable intravaginal sensing platform for continuous monitoring of pelvic floor activity, comprising a primary sensor array and associated elements.
Intended use: monitoring of pelvic floor function in adult women.

That was all. Lea read it three times. Then she sat back in her chair.

Intravaginal sensing platform. She knew where that was. She could feel it right now, if she clenched. The sensor platform, Abby had called it, on the table, with it just seated. It just sits there and listens. And here it was, in a memo, in plain English: a sensor. Monitoring. A medical device that watched the muscles, the way a heart monitor watched a heart.

It should have been a relief. It was exactly what Abby had told her. It matched.

She read it a fourth time, and stopped on two words.

Associated elements.

What elements? A sensor platform needed a sensor. It needed a battery, a radio, a casing. Those weren’t elements; those were the device. Associated meant separate. Somewhere else. Connected to it.

She put her hand, without meaning to, flat on her own breastbone, over the blouse, over the silk, over the bars.

Then she took it away.

She wrote to Priya. Professional. Bloodless. For the De Novo, I’ll need the full technical specification — sensor architecture, data handling, power, and a complete list of the “associated elements” referenced in the device description. When can I expect the annex?

Priya’s answer came back in eleven minutes. Annex attached. Some sections are restricted pending patent filing.

The annex was forty pages. Lea read every one of them that night, at the kitchen island, with a glass of wine Abby had poured. It was dense, careful engineering — the sensor array, materials, power, battery life, biocompatibility data from the trials, the healing compound, the data pipeline. It was good. It was thorough. It was all about listening: what the platform measured, how often, how precisely, where the data went. Page after page of it was exactly what she needed to file a sensing device.

And here and there, a grey box. [RESTRICTED — PATENT PENDING.] Section 4.3, Associated elements: grey. Section 7, Firmware architecture: two lines visible — The platform ships in a passive configuration. Additional firmware capabilities are — and then grey. A diagram that was mostly grey, with a faint outline of a female pelvis showing through the redaction, a small ring at the very top of the vaginal canal, and, around it — she tilted the screen, she leaned close — five tiny dots, faint as watermarks, with fine lines running from each of them to the ring.

She counted them twice. Five.

She closed the laptop.

“Problem?” said Abby, from the stove.

“The annex is redacted.”

“Some of it.”

“Section seven.” Lea kept her voice level. Lawyer voice. Not asking. Advising. “Additional firmware capabilities. If the device has capabilities beyond sensing, the FDA needs to know. That’s not optional, Abby, that’s the whole—”

“The device as filed is a sensor,” Abby said. “That’s what it does. That’s all it does, as of today.” She stirred something. “File it as a sensor. If it ever does anything else, we’ll tell them then.”

“If.”

“If.” Abby turned around. “Is that a question?”

Lea sat at the island with the laptop closed and the ring inside her and the five faint dots on a grey diagram burned onto the back of her eyes. Is that a question. It was. It was the only question. What else does it do. And it was a question about the second product, and she had asked about the second product four times, and she remembered every one of them, and what each had cost.

“No,” she said.

“Then file what you can,” said Abby. “Leave the rest to me.”

She filed it on February nineteenth, at 11:40 p.m., at the kitchen island, after three weeks and nine drafts. It was the best work she’d ever done — careful, precise, every claim supported, and every gap papered over with exactly the language the agency liked to see: a passive sensing platform for continuous monitoring of pelvic floor function in adult women. She had spent hours on the word passive. It was true. She’d checked. Everything Priya had let her see said it was true.

She signed the cover letter electronically. L. Calloway, General Counsel. She pressed submit. She went to bed and lay with her wrists tethered and the ring in her and her clit in its cage and felt, absurdly, proud.

Nine days later, looking for something else in the regulatory portal, she found the supplement.

It had been filed on February twentieth. The morning after hers. 8:15 a.m. Its cover letter was signed L. Calloway, General Counsel.

She couldn’t open it.

It was there, in the docket, with its date and its time and her name. And when she clicked it, the portal said: Confidential Commercial Information — access restricted to designated submitter contact. The designated submitter contact was not her. She clicked it again anyway. Access restricted. All she could see was the title, in the plain grey font of a federal database:

Supplement 1: Firmware Capabilities (HCP-2 v2.0).

She sat looking at it for a long time.

Firmware capabilities. Additional firmware capabilities are — grey.

It doesn’t do anything yet, Abby had said, on the table. Yet.

She did not let herself think the rest of it. She didn’t have the rest of it. That was the thing. She had a title and a version number and five faint dots on a diagram and a word, yet, and nothing else, nothing to stand on, nothing to reason from — and her mind, which had always been able to reason its way to the bottom of anything, went to the edge of the blank and found nothing there to hold. It wasn’t that she refused to understand. There was nothing to understand. Just a locked document with her own name on it, describing something inside her, that she was not allowed to read.

She walked down the hall to Abby’s office. She didn’t knock.

“You filed a supplement,” she said. “Under my name.”

Abby looked up from her screen. “You filed a supplement.”

“I did not. I filed the De Novo on the nineteenth at eleven-forty at night, and I went to bed, and someone filed a supplement at eight-fifteen the next morning with my e-signature on the cover letter — a supplement I can’t even open, Abby, it’s restricted, I’m the general counsel and I can’t read my own—”

“With your e-signature,” Abby agreed. “Which you applied.” She turned her screen. On it was a log — the portal’s audit trail. e-signature applied: L. Calloway. 19 Feb, 23:41. Documents: (2). “Two documents. The De Novo and the supplement. One signature. Queued submission. The supplement was set to go at eight-fifteen so it wouldn’t hit the same reviewer on the same day. Confidential treatment, because it’s trade secret. Contact designated as me, because it’s engineering.” She tilted her head. “You set that. Don’t you remember?”

Lea stared at the log.

Documents: (2).

She’d been tired. It had been almost midnight. She had been working on the De Novo for three weeks and she’d read it nine times and she’d been so proud and so tired and the ring had been in her and her clit had been throbbing in its cage the whole time, the whole three weeks, untouched, and she’d sat at the kitchen island with Abby cooking behind her and — had there been two? Had the signing screen said two? She could see it, she thought. A list. Her De Novo at the top. Had there been something underneath it? Something she’d scrolled past?

She didn’t know. She couldn’t see it. She could see the screen and the button and the warm kitchen light and Abby’s back at the stove and she couldn’t see what had been on the list.

“I didn’t read it,” she said. Very quietly. “If I signed it, I didn’t read it.”

“You signed it.” Abby’s voice was gentle. “Whether you read it is between you and your bar license.” She turned the screen back. “Would you like to file a correction? Tell the FDA your own general counsel’s signature on her own company’s submission wasn’t valid? On what grounds?”

Lea stood there.

On what grounds. She tried to think of them. Duress. She hadn’t been under duress; she’d been at a kitchen island drinking wine. Lack of capacity. She’d filed a flawless De Novo three minutes before. I didn’t know what I was signing. She was a lawyer. She’d told a hundred clients, a thousand: it doesn’t matter whether you read it. If you signed it, you agreed to it.

Forty-one pages of participant terms, and you hit I accept in four seconds.

“No,” she whispered.

“Then it’s filed.” Abby went back to her screen. “Close the door on your way out, would you? And Lea—” She didn’t look up. “That was close to a fifth question. I’m going to let it go. Don’t make me regret it.”

On the last day of February, drafting the NDA for the Verity regional sales meeting — the confidentiality agreement every attendee would sign before entering the closed afternoon session, which she was drafting because she was the general counsel and that was her job — Lea opened the attendee list Verity’s events team had sent over, to add the names as schedules to the agreement.

Sixty-two names. Regional sales directors from eleven countries. Marguerite Okafor, CEO. Her head of product, the man from the lab. Verity’s general counsel, from Lyon, whose voice Lea knew from a dozen calls.

And under Board of Directors (observing), three names. The second was Ward, Pauline.

Lea sat very still.

She remembered the water glass. The faint, considering frown. At 3:12 your heart rate jumped eleven beats and you stopped breathing for nine seconds.

She went to Abby’s office. She stood in the door.

“Pauline Ward is on the list,” she said.

Abby looked up. “She’s on their board. Board members get listed.” She went back to her screen.

“She’ll be in the room. In the afternoon session. She’ll—” Lea’s voice was going. “She sat across from me at Hadley. She watched me almost — she saw me, Abby, she saw what was happening to me, she went to Halloran, she’s the reason I—”

“She sent regrets.” Abby didn’t look up. She turned her laptop a few degrees so Lea could see it: an email, from a Verity events coordinator, that morning. Please note Ms. Ward has sent her regrets for the 14th; board observation will be Mr. Achterberg and Ms. Liu only. “Board members almost never come to sales meetings. They put their names down and then don’t show. You’ll want to strike her from the schedule.”

Lea read it twice. She felt the relief go through her so hard her knees nearly gave.

“Okay,” she said. “Okay. I’ll strike her.”

“Do.” Abby was already typing again. “And Lea — you’re welcome.”

Lea went back to her office and struck Pauline Ward from Schedule B of the confidentiality agreement, and saved it, and sat for a while with her hands in her lap, breathing.

It was only much later that she wondered why Abby had thought she’d want thanks for an email Abby hadn’t written.

HALO BIOMETRIC — PARTICIPANT NOTES (PRIVATE)

Subject: L.
Day: 86 (cycle 2).
Entry by: A.M.

Healing: excellent. All sites closed by day 82. Cage stays until the 14th. Nothing touches her until the room is full.

Day 69 (week 4): first time she’s seen me. Let her watch me come on the table. She thrust at the air for nine minutes. I didn’t touch her. I won’t. Her HR the next day never dropped below 88. I have, at last, made myself a weapon. It took longer than it should have, because I didn’t want to use it. I’ve stopped minding.

De Novo filed 19 Feb, flawless. Supplement queued under the same signature. She found it on day 84. Showed her the audit trail. She doesn’t remember what was on the signing screen, and now she never will. She tried to find grounds to contest it and couldn’t, because she’s an honest lawyer, and an honest lawyer knows a signature is a signature. Her own ethics did the work. Not me.

She found the supplement and couldn’t open it. Title only: Firmware Capabilities (HCP-2 v2.0). She counted the five dots on the annex diagram — twice — and then didn’t ask. She’s started to protect the surprise for me. She has no idea what she’s protecting.

Pauline: list received. L. found her name within the hour. Had Verity’s coordinator send regrets on P.'s behalf — P. agreed; thought it was funny. L. struck her from the NDA schedule herself. P. will sign a separate one, with me, and come in through the service corridor after the lights go down. L. thanked me.

P. asked by text if “your lawyer” would be in the room. Told her yes. Told her she’d recognize her if she looked carefully. She said she always looks carefully.

Sleep hood since week 5. Pink noise, and under it, at −24 dB, my voice: phrases from these notes, looped, randomized. Not enough to change her. Nothing could, at that level. Enough to tilt her. Enough that some mornings she thinks my sentences are her own. She caught one, once, near waking. I told her she was dreaming. Her trace agreed with me, so she did too.

Platform: still passive. Six weeks of baseline across all five sites. Every edge she’s had in her sleep is mapped.

Two weeks.